"Vaimse tervise kliinik. Tegevusluba L04146"

During the past decade, Marienthali Kliinik conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marienthali Kliinik" #1 collaborator was "ICON plc" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Marienthali Kliinik" are "Depressive Disorder, Major" (3 trials), "Major Depressive Disorder" (2 trials), "Anxiety Disorders" (1 trials), "Dementia" (1 trials) and "MDD" (1 trials). Many other conditions were trialed in "Marienthali Kliinik" in a lesser frequency.

Most popular intervention types in "Marienthali Kliinik" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vortioxetine" (4 trials), "Placebo" (2 trials), "Desvenlafaxine" (1 trials), "Fluoxetine 20mg/day" (1 trials) and "Lu AF11167 (1-2 mg/day)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marienthali Kliinik" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Marienthali Kliinik". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Marienthali Kliinik, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Marienthali Kliinik, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".